Adenocarcinoma vs Squamous NSCLC: How the Subtypes Differ

This episode breaks down two of the most common non-small cell lung cancer subtypes, adenocarcinoma and squamous cell carcinoma, and explains why getting the subtype right shapes the entire treatment plan.You'll learn:- Why adenocarcinoma and squamous cell carcinoma are subtypes of NSCLC, not competing diagnoses- Where each subtype typically starts in the lung and how they relate to smoking history- Why targeted therapy is more often an option for adenocarcinoma than for squamous cell carcinoma- How doctors confirm the subtype through biopsy, biomarker testing, and imaging- What large cell carcinoma and combined small cell carcinoma are, and how they differ from the two main subtypes- Why the subtype, not just the stage, shapes which treatments are realistic options- What biomarker testing checks for and why it matters for treatment planningNeither subtype is inherently more serious than the other. Getting an accurate diagnosis is what determines the right treatment path. For the full breakdown, read the article linked below.Blog Link: Adenocarcinoma vs Squamous NSCLC: How the Subtypes DifferSend us Fan MailThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.Author: Dr. CHRISTINA NG VAN TZE📍 Visit us at oncolifecentre.com 📞 Call: +60 3 2242 3260 📧 Book a consultation or ask a question — we're here to support your journey.